Joint Infection
29
4
6
13
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.9%
2 terminated out of 29 trials
86.7%
+0.2% vs benchmark
21%
6 trials in Phase 3/4
8%
1 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (29)
Side Effects of Antibiotics in Bone and Joint Infections
Real-component vs All-cement Articulating Spacers for Periprosthetic Knee Infection
Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection
Biological Collection From Samples From The Gut Microbiota In Patients Having A Bone Or Joint Infection Treated By A Suppressive Subcutaneous Antibiotherapy With Betalactamine (CARBAMICROBIOTA)
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
Performances of DendrisCHIP®OA in Bone and Joint Infections
Rate of Total Joint Infection 90-day After Surgery Following Irrigation With Next Science No-Rinse Solution vs SOC Alone
Study in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Occurring After Total Knee Arthroplasty (TKA)
Oral-only Antibiotics for Bone and Joint Infections in Children
Initial Oral Antibiotics for Bone and Joint Infections in Children
Can Intraosseous Antibiotics Improve the Results of Irrigation & Debridement and Prosthetic Retention for PJI?
Bacteriophage Clinical Trial for Periprosthetic Joint Infection of Multidrug Resistant Pseudomonas Aeruginosa
Prevalence of Pathogens in Synovial Fluid Obtained From Emergency Department Patients
Results of Extended Versus Single Dose Antibiotic Prophylaxis In Orthopedic Revision Arthroplasty in Nijmegen.
Cost of Off-label Antibiotics in Osteoarticular Infections
Microbiological Structure of Pathogens of Periprosthetic Infection of Large Joints in the Post-Covid Period
Interest in Probabilistic Antibiotic Therapy With Broad-spectrum Beta-lactams in Orthopedic Surgery
Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections
Biofilm Composition as a Predictive Biomarker for Prosthetic Joint Infection
Gut Microbiome of Patients Undergoing Antibiotic Therapy for Orthopedic Device-related Infection